HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission
APTcare
2 other identifiers
interventional
2,794
1 country
6
Brief Summary
This research, co-sponsored by the Centers for Disease Control and Prevention and the National Institute of Mental health, is conducted at six HIV clinics in the U.S. The research examines the effect of a clinic-based multi-component intervention delivered to HIV patients when they attend clinic for primary care. The study tests the hypothesis that the intervention will improve the viral load status of patients and improve attendance for HIV primary care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hiv
Started Jan 2014
Typical duration for not_applicable hiv
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 22, 2014
CompletedFirst Posted
Study publicly available on registry
January 24, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedMarch 20, 2025
March 1, 2025
1.4 years
January 22, 2014
March 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Percentage of patients with suppressed HIV (≤ 200 copies/mL)
At 9-month time point
Percentage of patients without a gap in HIV primary care (without a gap > 6 months)
From baseline to 9-month time point
Secondary Outcomes (2)
Change across time in log10 viral load values
From baseline to 9-month time point
HIV primary care appointment adherence
From baseline to 9-month time point
Study Arms (2)
Multi-component intervention
EXPERIMENTALComputer-based intervention (CBI) completed twice (separated by 2-4 months) among patients whose viral load exceeds 1000 copies/mL at time of enrollment. One-on-one counseling from a project Health Coach (three 1-hour sessions at the clinic and two follow-up phone calls at 1 and 3 months after last session). The counseling is offered to patients who do not show a 1-log reduction in their viral load after the first CBI or whose viral load remains above 200 copies/mL after two administrations of the CBI. Behavioral screening of patients at HIV primary care visits. Dissemination of palm cards with empowering messages at HIV primary care visits.
Standard of care control
NO INTERVENTIONHIV patients will continue to receive existing standard of care practices at the clinic without receiving the multi-component intervention.
Interventions
The computer-based intervention (CBI) is offered to patients whose viral load exceeds 1000 copies/mL at enrollment. Counseling is offered to patients whose viral load does not drop 1-log after the first CBI or remains above 200 copies/mL after completing two CBIs. The behavioral screener will be conducted of all patients at primary care visits. The patient completes the screener before seeing the provider. Responses are given to their provider who can use it in clinical care of the patient. At primary care visits, all patients are given a palm card containing 1 of 15 empowering messages before they leave the clinic. Messages cover three domains: adhering to antiretroviral therapy, regular care, and safer sex.
Eligibility Criteria
You may qualify if:
- All patients are eligible to receive behavioral screening and palm cards
- Patients with viral load exceeding 1000 copies/mL are eligible for the computer-based intervention and referral to counseling
You may not qualify if:
- Patients under the age of 18 (under 19 in Alabama) are not eligible for the computer-based intervention or referral to counseling because they cannot provide legal informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
1917 Clinic
Birmingham, Alabama, 35294, United States
Owen Clinic
San Diego, California, 92103, United States
Jackson Memorial Hospital
Miami, Florida, 33136, United States
Boston Medical Center
Boston, Massachusetts, 02118, United States
Thomas Street Health Center
Houston, Texas, 77009, United States
Harborview Medical Center
Seattle, Washington, 98104, United States
Related Publications (1)
Stirratt MJ, Marks G, O'Daniels C, Cachay ER, Sullivan M, Mugavero MJ, Dhanireddy S, Rodriguez AE, Giordano TP. Characterising HIV transmission risk among US patients with HIV in care: a cross-sectional study of sexual risk behaviour among individuals with viral load above 1500 copies/mL. Sex Transm Infect. 2018 May;94(3):206-211. doi: 10.1136/sextrans-2017-053178. Epub 2017 Nov 2.
PMID: 29097417DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas P Giordano, MD
Baylor College of Medicine
- PRINCIPAL INVESTIGATOR
Margaret Sullivan, MD
Boston University
- PRINCIPAL INVESTIGATOR
Matthew Golden, MD
University of Washington
- PRINCIPAL INVESTIGATOR
Edward Cachay, MD
University of California, San Diego
- PRINCIPAL INVESTIGATOR
Michael J Mugavero, MD
University of Alabama at Birmingham
- PRINCIPAL INVESTIGATOR
Allan E Rodriguez, MD
University of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2014
First Posted
January 24, 2014
Study Start
January 1, 2014
Primary Completion
June 1, 2015
Study Completion
October 1, 2016
Last Updated
March 20, 2025
Record last verified: 2025-03